Masimo (NASDAQ: MASI) announced today that O3® Regional Oximetry has received FDA clearance for use on neonatal indication and infant patients (<10 kg). O3...
Tag - neonatal indication for o3 regional oximetry
Research Papers
Press Releases
Events Calendar
Events
-
Epic UGM 20252025-08-18 - 2025-08-21
-
AI Leadership Strategy Summit2025-09-18 - 2025-09-19
-
Charmalot 20252025-09-19 - 2025-09-21
-
Civitas 2025 Annual Conference2025-09-28 - 2025-09-30